|
Real-time Estimate
Cboe BZX
12:45:29 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 29.62 USD | +0.56% |
|
+1.36% | +7.22% |
| 01/09 | Beam Therapeutics Inc. Appoints Eric Foster as Chief Commercial Officer | CI |
| 20/08 | Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder | RE |
Chart: Technical Analysis
CBOEUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BEAM | Delayed | |
CBOE
| BEAM | Real-time | |
|
Mexican S.E.
| BEAM * | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 31.03 | 37.92 | 34.81 |
| Spread/Res. | -4.22% | -21.62% | -14.62% |
| Spread/Supp. | +4.83% | +35.71% | +36.83% |
| Support | 28.35 | 21.9 | 21.72 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BEAM Stock
- Charts Beam Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
